XML 40 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Restructuring Actions and Exit Activities (Tables)
3 Months Ended
Mar. 31, 2021
2021 Restructuring Actions | Operational/Marketing Capability Restructuring  
Restructuring Cost and Reserve  
Schedule of restructuring charges by income statement line

(Millions)

First Quarter 2021

Cost of sales

$

1

Selling, general and administrative expenses

 

9

Research, development and related expenses

 

4

Total operating income impact

$

14

Components of restructuring by business segment

First Quarter 2021

(Millions)

    

Employee-Related

Safety and Industrial

$

2

Transportation and Electronics

3

Health Care

1

Consumer

1

Corporate and Unallocated

 

7

Total Operating Expense

$

14

Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Accrued restructuring action balances as of December 31, 2020

$

101

Incremental expense incurred in the first quarter of 2021

$

14

Cash payments

 

(14)

Accrued restructuring action balances as of March 31, 2021

$

101

2020 Restructuring Actions | Drug delivery business  
Restructuring Cost and Reserve  
Accrued restructuring action balances

(Millions)

    

Employee-Related

    

Asset-Related and Other

    

Total

 

Accrued divestiture-related restructuring action balances as of December 31, 2020

$

15

$

9

$

24

Cash payments

(1)

(1)

Adjustments

(1)

(1)

Accrued divestiture-related restructuring action balances as of March 31, 2021

$

13

$

9

$

22

2020 Restructuring Actions | Other Restructuring  
Restructuring Cost and Reserve  
Accrued restructuring action balances

(Millions)

    

Employee-Related

 

Accrued restructuring action balances as of December 31, 2020

$

24

Cash payments

(4)

Adjustments

(9)

Accrued restructuring action balances as of March 31, 2021

$

11